These findings indicate that targeting MDSCs or inhibiting pathways such as TIM-3 could be effective therapeutic strategies for increasing antiviral immunity and improving outcomes in Japanese encephalitis patients. This evidence concerns the gene HAVCR2 and Japanese encephalitis.